What does filgrastim cost, and what drives the price?
Filgrastim (a G-CSF used to reduce the risk of febrile neutropenia and support neutrophil recovery) is priced based on multiple factors: the brand or biosimilar used, the dose strength, number of vials/syringes per pack, and local pharmacy reimbursement and insurance coverage. Because filgrastim is widely sold as both originator and biosimilar products, the cash price can differ substantially by manufacturer and formulation (for example, vial vs prefilled syringe). [No source information was provided.]
How much do common filgrastim products cost (brand vs biosimilar)?
Prices vary by country and channel (retail pharmacy vs specialty pharmacy) and by which specific product is dispensed (originator vs biosimilar). Without the specific country, formulation (vial or prefilled syringe), strength (e.g., mcg/mL or microgram dose per syringe), and pack size, there is no single “filgrastim price” figure that can be stated accurately. [No source information was provided.]
How to estimate your out-of-pocket filgrastim cost quickly
To get a usable estimate, you typically need:
- The exact product name (including whether it is a biosimilar)
- The dose prescribed and dosing schedule
- The number of vials/syringes per month or per cycle
- Your country and whether you want cash price or insurance copay
With those details, you can convert the package price into a per-treatment or per-course estimate. [No source information was provided.]
Does “filgrastim price” mean vial price, syringe price, or per-course cost?
People often mean different things when they ask this:
- Price per vial/syringe (what the pharmacy charges for each unit)
- Price per pack (how it’s sold commercially)
- Price per course (total cost for the typical treatment duration)
If you share the regimen length (e.g., number of days), you can compute a per-course estimate once product-specific pricing is known. [No source information was provided.]
Are there cheaper alternatives (biosimilars) to reduce cost?
In many markets, biosimilars are priced lower than originator filgrastim and can reduce out-of-pocket cost when insurers prefer or require them. The cost outcome depends on formulary rules and prior authorization requirements. To compare accurately, you need the specific products available in your country. [No source information was provided.]
---
Quick questions so I can give a precise price range
1) What country are you in?
2) Do you mean filgrastim vial or prefilled syringe?
3) What strength and pack size (or the exact product name on the prescription)?
4) Are you asking for cash price or your insured copay?